Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer

NCT05445648 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Urinary Bladder Neoplasms

Interventions

DRUG: Tislelizumab Injection
PROCEDURE: Transurethral resection of bladder tumor
RADIATION: Adjuvant radiotherapy

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Collaborators

[object Object]